The Global Facial Injectable Market is
anticipated to reach over USD 18,819.04 Million by 2026 according to a new
research published by Polaris Market Research. Facial injectable products also
called as dermal fillers are products that benefit in facial transformation.
These facial injectable products are widely used to indulgence the early signs
of age as well as wrinkles thereby increasing the visual attractiveness.
Factors such as the rise in demand
to augment the visual look and growing popularity for negligibly intrusive
procedures majorly drive the market. In addition, the rise in elderly
population and introduction of improved facial injectable such as synthetic
calcium hydroxyl apatite fillers further anticipated boosting the market
growth. In recent time, growing demand for non-surgical processes for facial
transformation and modification is gaining global admiration. For instance,
according to the International Society of Aesthetic Plastic Surgery (ISAPS),
2017, non-surgical and surgical cosmetic techniques showed an overall rise of
9% from past years. Moreover, according to the same report in 2016, nonsurgical
procedures including injectable accounted for approximately 8 million globally.
The global Facial Injectable Market is segmented on the basis of products, end
users, and geography.
Get Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/global-facial-injectable-market/request-for-sample
Some major key players in global
Facial Injectable Market include Advanced Dermatology, Merz, Inc., Galderma
Laboratories, L.P., ColBar LifeScience Ltd., Allergan, Plc., Valeant
Pharmaceuticals North America LLC., Sanofi Biosurgery Inc. (Sanofi), Anika Therapeutics,
Inc., Suneva Medical, Inc.among others.
On the basis of products, the
Global Facial Injectable Market is segmented into Dermal Fillers/Injectable
Implants and Anti-aging/ Anti-wrinkle Injections. The Dermal Fillers/Injectable
Implants is further segmented into Hyaluronic Acid, Collagen Fillers, and
Synthetic Fillers such as Calcium hydroxylapatite and polymethyl methacrylate
microspheres. The Anti-aging/ Anti-wrinkle Injections is further categorized
into Botulinum toxin A and Poly-L-lactic acid (PLLA) micro particles. On the
basis of products, the hyaluronic acid segment is estimated to dominate the
market in 2017. Moreover, this segment is anticipated to show lucrative growth
during the forecast period. Cumulative use of hyaluronic acid as a dermal
filler in the cosmetic procedure is anticipated to support the market growth.
Hyaluronic acid has become an important part of cosmetics and aesthetic
surgeries due to its robust water retaining properties. In general, the
cosmetic-grade hyaluronic acid has the lower molecular weight which further
aids to retain water in the cells, releases antioxidants, form the deep
penetration of the product in the epidermis, and delays the aging progression.
On the basis of the end user, the global Facial Injectable Market is segmented
into Hospitals, Dermatology Clinics, Beauty Clinics, and Dermatology Research
Institutes. In 2017, hospital segment is estimated to dominate the global
market.
Special Discount Offer on Complete Report @ https://www.polarismarketresearch.com/industry-analysis/global-facial-injectable-market/request-for-discount-pricing
Key players are adopting partnerships
and product introduction strategies in order to fulfill the unmet aesthetic as
well as clinical needs thus, providing surgeons with better and novel options
further augmenting the growth of the facial injectable market. For instance, in
2017, the company Galderma collaborated with Colorescience to expand its
skincare solutions for persons that can be used in combination with orthodox
facial injectable aesthetic treatments.
Contact us-
Polaris Market Research
Phone: 1-646-568-9980
No comments:
Post a Comment
Please do not enter any spam link in the comment box...